Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Javier G Blanco

Showing results (21-30 of 54) with videos related to

Pageof 6
Sort By:
Mitochondrial DNA. Part A, DNA Mapping, Sequencing, and Analysis|June 19, 2014
Analysis of mtDNA, miR-155 and BACH1 expression in hearts from donors with and without Down syndromeErik Hefti, Adolfo Quiñones-Lombraña, Almedina Redzematovic, et al.
Pharmacogenomics|June 7, 2006
The role of genetic variability in drug metabolism pathways in breast cancer prognosisJi-Yeob Choi, Susan A Nowell, Javier G Blanco, et al.
Cardiovascular Toxicology|May 13, 2015
Role of DNA Methylation on the Expression of the Anthracycline Metabolizing Enzyme AKR7A2 in Human HeartCarrie C Hoefer, Adolfo Quiñones-Lombraña, Rachael Hageman Blair, et al.
Gene|August 31, 2020
Comparative genome-wide DNA methylation analysis in myocardial tissue from donors with and without Down syndromeRomina B Cejas, Jie Wang, Rachael Hageman-Blair, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|March 9, 2007
A functional genetic polymorphism on human carbonyl reductase 1 (CBR1 V88I) impacts on catalytic activity and NADPH binding affinityVanessa Gonzalez-Covarrubias, Debashis Ghosh, Sukhwinder S Lakhman, et al.
Molecular Pharmacology|June 16, 2007
Functional characterization of the promoter of human carbonyl reductase 1 (CBR1). Role of XRE elements in mediating the induction of CBR1 by ligands of the aryl hydrocarbon receptorSukhwinder S Lakhman, Xiaomin Chen, Vanessa Gonzalez-Covarrubias, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|November 22, 2008
Pharmacogenetics of human carbonyl reductase 1 (CBR1) in livers from black and white donorsVanessa Gonzalez-Covarrubias, Jianping Zhang, James L Kalabus, et al.
Toxicology Letters|February 16, 2006
Higher activity of polymorphic NAD(P)H:quinone oxidoreductase in liver cytosols from blacks compared to whitesVanessa Gonzalez Covarrubias, Sukhwinder S Lakhman, Alan Forrest, et al.
The AAPS Journal|February 14, 2018
Correction to: Pluripotent Stem Cell-Derived Human Tissue: Platforms to Evaluate Drug Metabolism and SafetyJose Meseguer-Ripolles, Salman R Khetani, Javier G Blanco, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|August 24, 2010
Expression of the anthracycline-metabolizing enzyme carbonyl reductase 1 in hearts from donors with Down syndromeJames L Kalabus, Carrie C Sanborn, Raqeeb G Jamil, et al.
Pageof 6

Showing results (21-30 of 54) with videos related to

Sort By:
Pageof 6
Mitochondrial DNA. Part A, DNA Mapping, Sequencing, and Analysis|June 19, 2014
Analysis of mtDNA, miR-155 and BACH1 expression in hearts from donors with and without Down syndromeErik Hefti, Adolfo Quiñones-Lombraña, Almedina Redzematovic, et al.
Pharmacogenomics|June 7, 2006
The role of genetic variability in drug metabolism pathways in breast cancer prognosisJi-Yeob Choi, Susan A Nowell, Javier G Blanco, et al.
Cardiovascular Toxicology|May 13, 2015
Role of DNA Methylation on the Expression of the Anthracycline Metabolizing Enzyme AKR7A2 in Human HeartCarrie C Hoefer, Adolfo Quiñones-Lombraña, Rachael Hageman Blair, et al.
Gene|August 31, 2020
Comparative genome-wide DNA methylation analysis in myocardial tissue from donors with and without Down syndromeRomina B Cejas, Jie Wang, Rachael Hageman-Blair, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|March 9, 2007
A functional genetic polymorphism on human carbonyl reductase 1 (CBR1 V88I) impacts on catalytic activity and NADPH binding affinityVanessa Gonzalez-Covarrubias, Debashis Ghosh, Sukhwinder S Lakhman, et al.
Molecular Pharmacology|June 16, 2007
Functional characterization of the promoter of human carbonyl reductase 1 (CBR1). Role of XRE elements in mediating the induction of CBR1 by ligands of the aryl hydrocarbon receptorSukhwinder S Lakhman, Xiaomin Chen, Vanessa Gonzalez-Covarrubias, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|November 22, 2008
Pharmacogenetics of human carbonyl reductase 1 (CBR1) in livers from black and white donorsVanessa Gonzalez-Covarrubias, Jianping Zhang, James L Kalabus, et al.
Toxicology Letters|February 16, 2006
Higher activity of polymorphic NAD(P)H:quinone oxidoreductase in liver cytosols from blacks compared to whitesVanessa Gonzalez Covarrubias, Sukhwinder S Lakhman, Alan Forrest, et al.
The AAPS Journal|February 14, 2018
Correction to: Pluripotent Stem Cell-Derived Human Tissue: Platforms to Evaluate Drug Metabolism and SafetyJose Meseguer-Ripolles, Salman R Khetani, Javier G Blanco, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|August 24, 2010
Expression of the anthracycline-metabolizing enzyme carbonyl reductase 1 in hearts from donors with Down syndromeJames L Kalabus, Carrie C Sanborn, Raqeeb G Jamil, et al.
Pageof 6